ome

An overview of oncogenic drivers in NSCLC

Agenda

Learning objectives:         

After watching this video viewer should be able to:

  • Identify the most common driver mutations in NSCLC
  • Describe differences in patient outcomes associated with common driver mutations in NSCLC

 

Faculty:

  • Albrecht Stenzinger (Germany)

More Info
13 Minutes
EM-94015 - Date of preparation: June 2022